Product
CKD-348(3)
1 clinical trial
1 indication
Indication
Hypertension and DyslipidemiaClinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348(3) With Coadministration of CKD-828, D097 and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-05-08